EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GLTO: Galecto Inc

28 Oct 25 18:41
LAST:

7.160

CHANGE:
 0.19		OPEN:
7.120		HIGH:
7.430		ASK:
0.000		VOLUME:
58.2K
CHG(%):
2.52		PREV:
7.345		LOW:
7.020		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Oct 257.1207.4307.0207.16058.2K
27 Oct 258.2608.3557.2257.34566.7K
24 Oct 258.0208.6108.0208.430175.1K
23 Oct 257.5008.3957.5008.290122.3K
22 Oct 258.1908.3907.7307.73098.7K
21 Oct 259.2109.3508.4308.53078.5K
20 Oct 259.3109.7509.2309.43095.2K
17 Oct 2510.20010.5659.5109.58090.5K
16 Oct 2511.86012.97010.70010.990215.7K
15 Oct 2510.83012.31010.53011.675163.4K

COMPANY PROFILE

Name:Galecto Inc
About:Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Sector:Healthcare
Industry:Biotechnology
Address:Ole Maaloes Vej 3, Copenhagen, Denmark, 2200
Website:https://galecto.com
CUSIP:36322Q107
CIK:0001800315
ISIN:US36322Q1076
FIGI:BBG00XMLGWC5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:7.798.8%
MA10:8.9224.5%
MA20:9.2128.6%
MA50:5.6526.7%
MA100:4.5557.4%
MA200:4.1572.4%
RSI14:37.46 
WPR14:-100.00 
MTM14:-7.59
ROC14:-0.51 
ATR:1.68 
Week High:9.3530.6%
Week Low:7.022.0%
Month High:31.70342.7%
Month Low:3.5072.4%
Year High:31.70342.7%
Year Low:2.01256.2%
Volatility:290.73 

RECENT SPLITS

Date Ratio
30 Aug 20241-25